Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library (Q33752827)

29 July 2017

title

Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library (English)

1 reference

29 July 2017

main subject

small molecule libraries

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21095183

31 August 2024

Christina Kalderén

2

0 references

Claes Dahlgren

6

object named as

Claes Dahlgren

1 reference

29 July 2017

Huamei Forsman

1

1 reference

29 July 2017

Anna Nordin

3

1 reference

29 July 2017

Erik Nordling

4

1 reference

29 July 2017

Annika Jernmalm Jensen

5

1 reference

29 July 2017

language of work or name

English

0 references

publication date

21 November 2010

1 reference

full work available at URL

29 July 2017

https://hal.archives-ouvertes.fr/hal-00654976/file/PEER_stage2_10.1016%252Fj.bcp.2010.11.005.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21095183

https://api.elsevier.com/content/article/PII:S0006295210008026?httpAccept=text/xml

31 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

https://api.elsevier.com/content/article/PII:S0006295210008026?httpAccept=text/plain

31 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

31 August 2024

published in

Biochemical Pharmacology

1 reference

29 July 2017

volume

81

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

402-411

1 reference

The molecular biology of leukocyte chemoattractant receptors

29 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Chemotaxis receptors and signaling

31 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Structure and function of leukocyte chemoattractant receptors

31 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Ligand recognition and activation of formyl peptide receptors in neutrophils

31 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family

31 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

NADPH oxidase activity: In the crossroad of neutrophil life and death

31 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

How human neutrophils kill and degrade microbes: an integrated view

31 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement.

31 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Annexin-1 modulates repair of gastric mucosal injury

31 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

A novel peptide agonist of formyl-peptide receptor-like 1 (ALX) displays anti-inflammatory and cardioprotective effects

31 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Anti-inflammatory and proresolving lipid mediators

31 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4

31 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Lipoxin A(4) metabolites/analogues from two commercial sources have no effects on TNF-alpha-mediated priming or activation through the neutrophil formyl peptide receptors

31 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

The beta-galactoside binding immunomodulatory lectin galectin-3 reverses the desensitized state induced in neutrophils by the chemotactic peptide f-Met-Leu-Phe: role of reactive oxygen species generated by the NADPH-oxidase and inactivation of the a

31 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1.

31 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

High-throughput screening for small-molecule activators of neutrophils: identification of novel N-formyl peptide receptor agonists

31 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

The pyrazolone originally reported to be a formyl peptide receptor (FPR) 2/ALX-selective agonist is instead an FPR1 and FPR2/ALX dual agonist

31 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition.

31 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents

31 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results

31 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Efficient generation, storage, and manipulation of fully flexible pharmacophore multiplets and their use in 3-D similarity searching

31 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Cell permeant polyphosphoinositide-binding peptides that block cell motility and actin assembly

31 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Separation of Leucocytes: Improved Cell Purity by Fine Adjustments of Gradient Medium Density and Osmolality

31 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils

31 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Respiratory burst in human neutrophils

31 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Oxygen radical-induced natural killer cell dysfunction: role of myeloperoxidase and regulation by serotonin

31 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

A methodological approach to studies of desensitization of the formyl peptide receptor: Role of the read out system, reactive oxygen species and the specific agonist used to trigger neutrophils

31 August 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

The peptide Trp-Lys-Tyr-Met-Val-D-Met activates neutrophils through the formyl peptide receptor only when signaling through the formylpeptide receptor like 1 is blocked. A receptor switch with implications for signal transduction studies with inhibi

31 August 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor

31 August 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide

31 August 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

The FPR2-induced rise in cytosolic calcium in human neutrophils relies on an emptying of intracellular calcium stores and is inhibited by a gelsolin-derived PIP2-binding peptide

31 August 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients

31 August 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.

31 August 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Circulating mitochondrial DAMPs cause inflammatory responses to injury

31 August 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists

31 August 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Discovery of selective probes and antagonists for G-protein-coupled receptors FPR/FPRL1 and GPR30

31 August 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

High-throughput screening with HyperCyt flow cytometry to detect small molecule formylpeptide receptor ligands

31 August 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes

31 August 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

New 'chemical probes' to examine the role of the hFPRL1 (or ALXR) receptor in inflammation

31 August 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

A novel nonpeptide ligand for formyl peptide receptor-like 1.

31 August 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics

31 August 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Priming by tumor necrosis factor-α of human neutrophil NADPH-oxidase activity induced by anti-proteinase-3 or anti-myeloperoxidase antibodies

31 August 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils

31 August 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Newcastle disease virus neuraminidase primes neutrophils for stimulation by galectin-3 and formyl-Met-Leu-Phe

31 August 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Lipopolysaccharide-induced granule mobilization and priming of the neutrophil response to Helicobacter pylori peptide Hp(2-20), which activates formyl peptide receptor-like 1.

31 August 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

Cytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophils

31 August 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2010.11.005

31 August 2024

Identifiers

1 reference

29 July 2017

1 reference